Tatsuya Okuno

Kobe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113.

Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113.

Journal: International journal of clinical oncology

Published: April 21, 2024

Ultra-high temperature Soret effect in a silicate melt: SiO2 migration to cold side.

Ultra-high temperature Soret effect in a silicate melt: SiO2 migration to cold side.

Journal: The Journal of chemical physics

Published: July 11, 2023

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Journal: Oncology letters

Published: March 16, 2023

Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807.

Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: July 13, 2022

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).

Journal: The oncologist

Published: June 22, 2022

A Single-Arm Confirmatory Study of Definitive Chemoradiation Therapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).

A Single-Arm Confirmatory Study of Definitive Chemoradiation Therapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).

Journal: International journal of radiation oncology, biology, physics

Published: March 04, 2022

Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201.

Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 08, 2021

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Journal: The oncologist

Published: June 24, 2020

Neoadjuvant Triplet Combination Chemotherapy(UDON Therapy)in Esophageal Cancer Patients with Impaired Renal Function-A Retrospective Study

Neoadjuvant Triplet Combination Chemotherapy(UDON Therapy)in Esophageal Cancer Patients with Impaired Renal Function-A Retrospective Study

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 12, 2020

A prospective compound screening contest identified broader inhibitors for Sirtuin 1.

A prospective compound screening contest identified broader inhibitors for Sirtuin 1.

Journal: Scientific reports

Published: July 04, 2019

Clinical features of intravascular large B-cell lymphoma: a single-institute retrospective analysis

Clinical features of intravascular large B-cell lymphoma: a single-institute retrospective analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 10, 2019

Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Journal: Nature microbiology

Published: February 02, 2019

Showing 1-12 of 47

Last Updated: 09/26/2026